A healthcare worker holds a vial of the Moderna COVID-19 Vaccine at a pop-up vaccination site operated by SOMOS Community Care during the coronavirus disease (COVID-19) pandemic in New York, January 29, 2021.Mike Segar | ReutersModerna’s Covid-19 vaccine was more than 90% effective at protecting against Covid and more than 95% effective against severe disease up to six months after the second dose, the company said Tuesday, citing updated data from its phase three clinical trial.The update brings Moderna a step closer to filing its request for full U.S. approval for its vaccine. Full approval requires a more rigorous review process to …
